Stability Data Clause Samples
Stability Data. Notwithstanding anything herein to the contrary, Santarus agrees to transfer to GSK all stability data related to the Licensed Products Controlled by Santarus that it may generate from time to time during the Term.
Stability Data. Without limiting Santarus’ obligations in Section 5.3.1, GSK shall have the right and be responsible for generating at its expense any stability data necessary to expeditiously file for and obtain Marketing Authorizations throughout the GSK Territory to the extent such data is beyond the current or scheduled Santarus stability programs. In the event that Santarus wishes to use any of this stability data in Regulatory Filings for Licensed Products outside of the GSK Territory and Territory under the Distribution Agreement, excluding uses by Santarus as required by Applicable Law, the Parties shall negotiate in good faith for appropriate compensation by Santarus for the use of such stability data, such compensation to be determined by reference to the anticipated commercial value respectively to GSK and Santarus of using such data.
Stability Data. Avigen shall Notify Bayer of any stability failures in routine stability testing of the Product in accordance with the Product Specifications within [...*...] of Avigen confirming such failure if such failure could require notification of a regulatory authority, could prevent release of Product or could warrant recall of Product.
Stability Data. Norgine shall have the right and be responsible for generating at its expense any stability data necessary to file for and obtain Marketing Authorizations throughout the Territory. Santarus shall have the right to use any such stability data generated by Norgine for applications outside the Territory or outside the Field, pursuant to the terms of the license set forth in Section 2.2.
Stability Data. Without limiting Santarus’ obligations in Section 5.3.1, GSK shall have the right and be responsible for generating at its expense any stability data necessary to expeditiously file for and obtain Marketing Authorizations throughout the GSK Territory to the extent such data is beyond the current or scheduled Santarus stability programs. In the event that Santarus wishes to use any of this stability data in Regulatory Filings for Licensed Products outside of the GSK Territory and Territory under the Distribution Agreement, [***]. *** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Stability Data. DUSA shall annually make available to Schering copies of stability data for the Collaboration Products. Any significant trends should be promptly reported.